301 related articles for article (PubMed ID: 16557208)
1. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
[TBL] [Abstract][Full Text] [Related]
2. Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.
Amin A; Moustafa H; Ahmed E; El-Toukhy M
J Neurooncol; 2012 Feb; 106(3):579-87. PubMed ID: 21912937
[TBL] [Abstract][Full Text] [Related]
3. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
[TBL] [Abstract][Full Text] [Related]
4. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
6. [Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds].
Isobe T; Matsumura A; Anno I; Nagatomo Y; Yoshizawa T; Itai Y; Nose T
No Shinkei Geka; 2003 Feb; 31(2):167-72. PubMed ID: 12616652
[TBL] [Abstract][Full Text] [Related]
7. Metabolic characteristics of intracranial metastases, detected by single-voxel proton magnetic resonance spectroscopy, are seemingly not predictive for tumor response to gamma knife radiosurgery.
Chernov M; Hayashi M; Izawa M; Nakaya K; Ono Y; Usukura M; Yoshida S; Kato K; Muragaki Y; Nakamura R; Iseki H; Hori T; Takakura K
Minim Invasive Neurosurg; 2007 Aug; 50(4):233-8. PubMed ID: 17948183
[TBL] [Abstract][Full Text] [Related]
8. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
9. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS.
Chernov M; Hayashi M; Izawa M; Ochiai T; Usukura M; Abe K; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
Minim Invasive Neurosurg; 2005 Aug; 48(4):228-34. PubMed ID: 16172969
[TBL] [Abstract][Full Text] [Related]
12. [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
Dhermain F; Ducreux D; Bidault F; Bruna A; Parker F; Roujeau T; Beaudre A; Armand JP; Haie-Meder C
Bull Cancer; 2005 Apr; 92(4):333-42. PubMed ID: 15888390
[TBL] [Abstract][Full Text] [Related]
13. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
14. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
15. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
Chernov MF; Hayashi M; Izawa M; Usukura M; Yoshida S; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
Brain Tumor Pathol; 2006 Apr; 23(1):19-27. PubMed ID: 18095115
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction.
Ibrahim T; Bülow HP; Hackl T; Hörnke M; Nekolla SG; Breuer M; Schömig A; Schwaiger M
J Am Coll Cardiol; 2007 Jan; 49(2):208-16. PubMed ID: 17222732
[TBL] [Abstract][Full Text] [Related]
17. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
18. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
Kumar A; Kaushik S; Tripathi RP; Kaur P; Khushu S
Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
[TBL] [Abstract][Full Text] [Related]
19. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
Neumann DR; Obuchowski NA; Difilippo FP
J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer.
Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S
Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
